Biopharmaceutical Outsourcing Market Opportunities 2031
The biopharmaceutical industry is one of the significant contributors to global economic progress. Due to globalization, outsourcing of the biopharmaceutical processes has progressed to a great extent. Outsourcing also helped corporate in cost reduction and better focus on core business segments. The complexity of operations and technology-oriented industry companies started finding it feasible to outsource functions to experts. Outsourcing is the cost-saving alternative of biopharmaceutical business in the strategic decision.
MARKET DYNAMICS
Competitive market and advent of generics is an opportunity for small pharma companies to drive the augmentation of the biopharmaceutical outsourcing market. However, rising cost of drug discovery, regulatory policies and drug recalls are worry factors that may hinders the enlargement of the biopharmaceutical outsourcing market.
MARKET SCOPE
The "Biopharmaceutical Outsourcing Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biopharmaceutical outsourcing market with detailed market segmentation by service. The biopharmaceutical outsourcing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biopharmaceutical outsourcing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biopharmaceutical outsourcing market is segmented on the basis of service. Based on service, the market is segmented as clinical trials, drug discovery, api development, contract production and packaging, non-clinical services, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biopharmaceutical outsourcing market based onvarious segments.It also provides market size and forecast estimates from year 2021 to2031with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biopharmaceutical outsourcing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biopharmaceutical outsourcing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biopharmaceutical outsourcing market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biopharmaceutical outsourcing market based onvarious segments.It also provides market size and forecast estimates from year 2021 to2031with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biopharmaceutical outsourcing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biopharmaceutical outsourcing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biopharmaceutical outsourcing market in these regions.
MARKET PLAYERS
The report covers key developments in the biopharmaceutical outsourcing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biopharmaceutical outsourcing market are anticipated to have lucrative growth opportunities in the future with the rising demand for biopharmaceutical outsourcing in the global market. Below mentioned is the list of few companies engaged in the biopharmaceutical outsourcing market.
The report also includes the profiles of key players in biopharmaceutical outsourcing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- SARTORIUS AG
- EMCURE PHARMACEUTICALS LTD
- BIOPHARMA SERVICES INC.
- LAMBDA THERAPEUTIC RESEARCH LTD.
- BAXTER HEALTHCARE CORPORATION
- KEYRUS BIOPHARMA
- QUINTILES INC.
- APTUIT LLC
- KBI BIOPHARM
- ICON PLC
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical Outsourcing Market - By Service
1.3.2 Biopharmaceutical Outsourcing Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOPHARMACEUTICAL OUTSOURCING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOPHARMACEUTICAL OUTSOURCING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOPHARMACEUTICAL OUTSOURCING MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOPHARMACEUTICAL OUTSOURCING MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE
7.1. OVERVIEW
7.2. SERVICE MARKET FORECASTS AND ANALYSIS
7.3. CLINICAL TRIALS
7.3.1. Overview
7.3.2. Clinical Trials Market Forecast and Analysis
7.4. DRUG DISCOVERY
7.4.1. Overview
7.4.2. Drug Discovery Market Forecast and Analysis
7.5. API DEVELOPMENT
7.5.1. Overview
7.5.2. API Development Market Forecast and Analysis
7.6. CONTRACT PRODUCTION AND PACKAGING
7.6.1. Overview
7.6.2. Contract Production and Packaging Market Forecast and Analysis
7.7. NON-CLINICAL SERVICES
7.7.1. Overview
7.7.2. Non-Clinical Services Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BIOPHARMACEUTICAL OUTSOURCING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Biopharmaceutical Outsourcing Market Overview
8.1.2 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.1.3 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.1.4 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.1.4.1 United States Biopharmaceutical Outsourcing Market
8.1.4.1.1 United States Biopharmaceutical Outsourcing Market by Service
8.1.4.2 Canada Biopharmaceutical Outsourcing Market
8.1.4.2.1 Canada Biopharmaceutical Outsourcing Market by Service
8.1.4.3 Mexico Biopharmaceutical Outsourcing Market
8.1.4.3.1 Mexico Biopharmaceutical Outsourcing Market by Service
8.2. EUROPE
8.2.1 Europe Biopharmaceutical Outsourcing Market Overview
8.2.2 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.2.3 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.2.4 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Biopharmaceutical Outsourcing Market
8.2.4.1.1 Germany Biopharmaceutical Outsourcing Market by Service
8.2.4.2 France Biopharmaceutical Outsourcing Market
8.2.4.2.1 France Biopharmaceutical Outsourcing Market by Service
8.2.4.3 Italy Biopharmaceutical Outsourcing Market
8.2.4.3.1 Italy Biopharmaceutical Outsourcing Market by Service
8.2.4.4 Spain Biopharmaceutical Outsourcing Market
8.2.4.4.1 Spain Biopharmaceutical Outsourcing Market by Service
8.2.4.5 United Kingdom Biopharmaceutical Outsourcing Market
8.2.4.5.1 United Kingdom Biopharmaceutical Outsourcing Market by Service
8.2.4.6 Rest of Europe Biopharmaceutical Outsourcing Market
8.2.4.6.1 Rest of Europe Biopharmaceutical Outsourcing Market by Service
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Biopharmaceutical Outsourcing Market Overview
8.3.2 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.3.3 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.3.4 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Biopharmaceutical Outsourcing Market
8.3.4.1.1 Australia Biopharmaceutical Outsourcing Market by Service
8.3.4.2 China Biopharmaceutical Outsourcing Market
8.3.4.2.1 China Biopharmaceutical Outsourcing Market by Service
8.3.4.3 India Biopharmaceutical Outsourcing Market
8.3.4.3.1 India Biopharmaceutical Outsourcing Market by Service
8.3.4.4 Japan Biopharmaceutical Outsourcing Market
8.3.4.4.1 Japan Biopharmaceutical Outsourcing Market by Service
8.3.4.5 South Korea Biopharmaceutical Outsourcing Market
8.3.4.5.1 South Korea Biopharmaceutical Outsourcing Market by Service
8.3.4.6 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market
8.3.4.6.1 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market by Service
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Biopharmaceutical Outsourcing Market Overview
8.4.2 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.4.3 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.4.4 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Biopharmaceutical Outsourcing Market
8.4.4.1.1 South Africa Biopharmaceutical Outsourcing Market by Service
8.4.4.2 Saudi Arabia Biopharmaceutical Outsourcing Market
8.4.4.2.1 Saudi Arabia Biopharmaceutical Outsourcing Market by Service
8.4.4.3 U.A.E Biopharmaceutical Outsourcing Market
8.4.4.3.1 U.A.E Biopharmaceutical Outsourcing Market by Service
8.4.4.4 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market
8.4.4.4.1 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market by Service
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Biopharmaceutical Outsourcing Market Overview
8.5.2 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.5.3 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.5.4 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Biopharmaceutical Outsourcing Market
8.5.4.1.1 Brazil Biopharmaceutical Outsourcing Market by Service
8.5.4.2 Argentina Biopharmaceutical Outsourcing Market
8.5.4.2.1 Argentina Biopharmaceutical Outsourcing Market by Service
8.5.4.3 Rest of South and Central America Biopharmaceutical Outsourcing Market
8.5.4.3.1 Rest of South and Central America Biopharmaceutical Outsourcing Market by Service
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOPHARMACEUTICAL OUTSOURCING MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIOPHARMACEUTICAL OUTSOURCING MARKET, KEY COMPANY PROFILES
11.1. SARTORIUS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EMCURE PHARMACEUTICALS LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOPHARMA SERVICES INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LAMBDA THERAPEUTIC RESEARCH LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAXTER HEALTHCARE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KEYRUS BIOPHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. QUINTILES INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. APTUIT LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. KBI BIOPHARM
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ICON PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. SARTORIUS AG
2. EMCURE PHARMACEUTICALS LTD
3. BIOPHARMA SERVICES INC.
4. LAMBDA THERAPEUTIC RESEARCH LTD.
5. BAXTER HEALTHCARE CORPORATION
6. KEYRUS BIOPHARMA
7. QUINTILES INC.
8. APTUIT LLC
9. KBI BIOPHARM
10. ICON PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For